In addition, there are many clinical trials underway for FAP-2286, which involve solid tumors such as breast, pancreas, sarcoma, prostate cancer (NCT04621435) [241], and pathologic fibrosis such as idiopathic pulmonary fibrosis, cirrhosis, and cardiac fibrosis (NCT05180162) [242]. Here, FAP is linked to prostate cancer.